The Ensign Group Inc (ENSG)

Return on equity (ROE)

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 297,973 209,399 224,681 194,652 170,478
Total stockholders’ equity US$ in thousands 1,837,110 1,491,860 1,247,330 1,020,770 818,077
ROE 16.22% 14.04% 18.01% 19.07% 20.84%

December 31, 2024 calculation

ROE = Net income ÷ Total stockholders’ equity
= $297,973K ÷ $1,837,110K
= 16.22%

The Return on Equity (ROE) of The Ensign Group Inc has shown a slight decrease over the past five years, declining from 20.84% as of December 31, 2020, to 16.22% as of December 31, 2024. This downward trend indicates that the company's ability to generate profit from its shareholders' equity has weakened over the period. Despite experiencing fluctuations, the ROE has remained relatively healthy, although the decreasing trend may warrant further investigation into the company's financial performance and management of equity capital. It is essential for investors and stakeholders to closely monitor this metric to assess the effectiveness of the company's capital utilization and profitability.


Peer comparison

Dec 31, 2024

Company name
Symbol
ROE
The Ensign Group Inc
ENSG
16.22%
National HealthCare Corporation
NHC
10.40%